Viewing Study NCT03008408

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 10:57 AM

Ignite Modification Date: 2026-02-28 @ 5:31 AM

Study NCT ID: NCT03008408

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-11-21

First Post: 2016-12-28

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

Sponsor: M.D. Anderson Cancer Center

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief	Condition Text	View

None	Recurrent Endometrial Carcinoma	View
None	Recurrent Endometrial Endometrioid Adenocarcinoma	View
None	Refractory Endometrial Carcinoma	View
None	Refractory Endometrial Endometrioid Adenocarcinoma	View
None	Stage III Uterine Corpus Cancer AJCC v8	View
None	Stage IIIA Uterine Corpus Cancer AJCC v8	View
None	Stage IIIB Uterine Corpus Cancer AJCC v8	View
None	Stage IIIC Uterine Corpus Cancer AJCC v8	View
None	Stage IIIC1 Uterine Corpus Cancer AJCC v8	View
None	Stage IIIC2 Uterine Corpus Cancer AJCC v8	View
None	Stage IV Uterine Corpus Cancer AJCC v8	View
None	Stage IVA Uterine Corpus Cancer AJCC v8	View
None	Stage IVB Uterine Corpus Cancer AJCC v8	View

Keywords: